Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma.

Pediatric neurosurgery - 1 Jan 2021

Yamasaki Fumiyuki, Nishibuchi Ikuno, Karakawa Shuhei, Kaichi Yoko, Kolakshyapati Manish, Takano Motoki, Yonezawa Ushio, Imano Nobuki, Taguchi Akira, Shimomura Maiko, Taniguchi Maki, Onishi Shumpei, Okada Satoshi, Awai Kazuo, Sugiyama Kazuhiko, Nagata Yasushi

Abstract excerpt

PURPOSE: The T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign was previously reported as a diagnostic indicator of diffuse astrocytoma, isocitrate dehydrogenase-mutant, and 1p/19q noncodeletion. Subsequently, it was reported that the same findings were observed in diffuse intrinsic pontine glioma (DIPG). We investigated the clinical significance of T2-FLAIR mismatch sign in DIPG. METHODS: Twenty-one...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gadolinium
Share to Adolescent

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Astrocytoma

Share to Brain Stem Neoplasms

Share to Contrast Media

Share to Glioma

Share to Mutation

Source

Identifiers

PMID: 33535215
DOI: 10.1159/000513360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma.PMID 33535215Read ↗

Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma.Semantic proximity Read ↗

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.Semantic proximity Read ↗

Radiogenomic association between the T2-FLAIR mismatch sign and IDH mutation status in adult patients with lower-grade gliomas: an updated systematic review and meta-analysis.Semantic proximity Read ↗

T2-FLAIR mismatch sign: a roadmap of pearls and pitfalls.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.Semantic proximity Read ↗

Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction.Semantic proximity Read ↗

T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings.Semantic proximity Read ↗

"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.Semantic proximity Read ↗

T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.Semantic proximity Read ↗

Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of IDH-mutated gliomas.Semantic proximity Read ↗

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.Semantic proximity Read ↗

Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.